Systemic inflammatory response syndrome associated with amifostine.
Shaw
P J
PJ
Oncology Unit, Royal Alexandra Hospital for Children, Sydney, New South Wales, Australia. peters@nch.edu.au
Bleakley
M
M
D004999:Amifostine / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D020295:Brain Stem Neoplasms / Q000188:drug therapy; D002675:Child, Preschool; D003875:Drug Eruptions / Q000209:etiology*; D004487:Edema / Q000139:chemically induced; D004890:Erythema / Q000139:chemically induced; D005334:Fever / Q000139:chemically induced; D005910:Glioma / Q000188:drug therapy; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D008297:Male; D011537:Pruritus / Q000139:chemically induced; D012871:Skin Diseases / Q000139:chemically induced; D018746:Systemic Inflammatory Response Syndrome / Q000139:chemically induced*
D000970:Antineoplastic Agents; D004999:Amifostine